Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Commission announces reorganisation of portfolios:

This article was originally published in Clinica

Executive Summary

European medical device legislation will in future be administered by the directorate general (DG) for enterprise following the reorganisation of the Commission, rather than by the new DG for health and consumer protection (see Clinica No 864, p 7). "This will not change our approach," said a Commission spokesman. The enterprise DG has been created by merging the DGs that represented industry and small and medium-sized enterprises. Its commissioner-designate is Erkki Liikanen, a former minister of finance in Finland. The European Parliament will vote on September 15 to formally approve the reorganisation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT079028

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel